Outlook Therapeutics, Inc. - OTLK
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 17
Latest filed: Apr 24, 2026
| Form | Count |
|---|---|
| 8-K | 15 |
| SCHEDULE 13G | 1 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 24, 2026 | SCHEDULE 13G | — | 0001213900-26-047616 | View |
| Apr 23, 2026 | 8-K | Apr 22, 2026 | 0001104659-26-047741 | View |
| Apr 21, 2026 | 8-K | Apr 21, 2026 | 0001104659-26-046014 | View |
| Apr 07, 2026 | 8-K | Apr 07, 2026 | 0001104659-26-040387 | View |
| Mar 25, 2026 | 8-K | Mar 23, 2026 | 0001104659-26-034601 | View |
| Mar 16, 2026 | 8-K | Mar 13, 2026 | 0001104659-26-028103 | View |
| Mar 11, 2026 | 8-K | Mar 06, 2026 | 0001104659-26-026465 | View |
| Mar 10, 2026 | 8-K | Mar 10, 2026 | 0001104659-26-025893 | View |
| Mar 05, 2026 | 8-K | Mar 05, 2026 | 0001104659-26-024189 | View |
| Feb 18, 2026 | 8-K | Feb 18, 2026 | 0001104659-26-017118 | View |
| Feb 17, 2026 | 8-K | Feb 17, 2026 | 0001104659-26-015887 | View |
| Feb 11, 2026 | 8-K | Feb 11, 2026 | 0001104659-26-013470 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | — | 0001178913-26-000311 | View |
| Jan 02, 2026 | 8-K | Dec 31, 2025 | 0001104659-26-000066 | View |
| Dec 19, 2025 | 8-K | Dec 19, 2025 | 0001104659-25-122786 | View |
| Nov 13, 2025 | 8-K | Nov 13, 2025 | 0001104659-25-111316 | View |
| Nov 03, 2025 | 8-K | Nov 03, 2025 | 0001104659-25-105633 | View |